Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists

R R Ruffolo Jr, J E Waddell, R R Ruffolo Jr, J E Waddell

Abstract

1 Noradrenaline and a series of imidazolines were used to characterized and differentiate the postsynaptic alpha-adrenoceptors of rat and rabbit aortae. 2 Dose-response curves in each tissue revealed marked differences in the profile of agonist activity among the compounds. Based on the ED50 values for each compound, a rank order of potency of oxymetazoline greater than noradrenaline greater than tramazoline greater than tetrahydrozoline greater than clonidine was obtained in rabbit aorta and an order of noradrenaline greater than clonidine greater than tramazoline greater than oxymetazoline was obtained in rat aorta. Tetrahydrozoline had no agonist activity in rat aorta. 3 Dissociation constants were determined for each agonist in rat and rabbit aortae. Again, differences between the tissues were observed to the extent that the rank order of affinities for the imidazolines were exactly opposite for the two tissues. In rabbit aorta the order was, oxymetazoline greater than tramazoline greater than tetrahydrozoline greater than clonidine, whereas in rat aorta it was, clonidine greater than tetrahydrozoline greater then tramazoline greater than oxymetazoline. The extremes in tissue selectivity were observed with clonidine, which had approximately 125 fold higher affinity in rat aorta, and oxymetazoline, which had approximately 4 times higher affinity in rabbit aorta. 4 The absolute values of relative efficacies of the imidazolines studied, and their rank order, also differed between the two tissues. The relative efficacies of oxymetazoline and tramazoline were more than 15 fold greater in rabbit aorta than in rat aorta. Furthermore, tetrahydrozoline had a greater relative efficacy than clonidine in rabbit aorta while the converse was true in rat aorta. 5 Differences in the rank order of potency, affinity and relative efficacy of noradrenaline and a series of imidazolines in rat and rabbit aortae indicate that the postsynaptic alpha-adrenoceptors in these tissues are different. While the postsynaptic alpha-adrenoceptor of rabbit aorta is clearly of the alpha 1-subtype, the exact nature of the postsynaptic alpha-receptor of rat aorta is not clear. The unique alpha-receptor of rat aorta has properties of both alpha 1- and alpha 2-adrenoceptors.

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):5-7
    1. Eur J Pharmacol. 1981 Oct 15;75(1):57-60
    1. Arch Int Pharmacodyn Ther. 1981 Nov;254(1):43-57
    1. Biochem Pharmacol. 1982 Feb 15;31(4):467-84
    1. J Pharmacol Exp Ther. 1982 May;221(2):309-14
    1. Arch Int Pharmacodyn Ther. 1954 Sep 1;99(1):32-49
    1. Br J Pharmacol Chemother. 1956 Dec;11(4):379-93
    1. Br J Pharmacol Chemother. 1959 Mar;14(1):48-58
    1. Arch Int Pharmacodyn Ther. 1963;143:299-330
    1. J Pharmacol Exp Ther. 1963 Oct;142:39-58
    1. J Pharm Sci. 1966 Apr;55(4):359-67
    1. J Pharmacol Exp Ther. 1969 Nov;170(1):117-22
    1. J Pharmacol Exp Ther. 1972 Feb;180(2):317-25
    1. J Pharmacol Exp Ther. 1975 Nov;195(2):362-71
    1. J Pharmacol Exp Ther. 1976 Apr;197(1):66-78
    1. J Pharm Pharmacol. 1977 Mar;29(3):129-34
    1. J Pharm Pharmacol. 1978 Mar;30(3):167-72
    1. Nature. 1978 May 11;273(5658):164-6
    1. Br J Pharmacol. 1978 Oct;64(2):293-300
    1. J Pharmacol Exp Ther. 1979 Jun;209(3):429-36
    1. J Pharmacol Exp Ther. 1979 Oct;211(1):74-9
    1. J Pharmacol Exp Ther. 1979 Dec;211(3):733-8
    1. J Pharmacol Exp Ther. 1980 May;213(2):267-72
    1. J Pharmacol Exp Ther. 1980 Sep;214(3):535-40
    1. J Pharmacol Methods. 1980 Sep;4(2):165-78
    1. J Pharmacol Exp Ther. 1980 Jun;213(3):557-61
    1. Circ Res. 1981 Jun;48(6 Pt 1):875-84
    1. J Pharmacol Exp Ther. 1981 May;217(2):235-40
    1. Naunyn Schmiedebergs Arch Pharmacol. 1980 Nov;314(3):249-58
    1. J Pharmacol Exp Ther. 1981 Jul;218(1):154-60

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner